4//SEC Filing
Wallar Gina M 4
Accession 0001077183-22-000038
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:56 PM ET
Size
19.2 KB
Accession
0001077183-22-000038
Insider Transaction Report
Form 4
Wallar Gina M
President, Pharma Services
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+28,506→ 28,506 totalExercise: $21.41Exp: 2029-03-01→ Common Stock (28,506 underlying) - Award
Common Stock
2022-03-01+11,677→ 33,443 total
Holdings
- 10,126
Stock Option (Right to Buy)
Exercise: $43.95Exp: 2028-07-05→ Common Stock (10,126 underlying) - 6,667
Stock Option (Right to Buy)
Exercise: $9.22Exp: 2023-04-19→ Common Stock (6,667 underlying) - 7,879
Stock Option (Right to Buy)
Exercise: $27.34Exp: 2027-05-01→ Common Stock (7,879 underlying) - 8,595
Stock Option (Right to Buy)
Exercise: $48.99Exp: 2028-05-01→ Common Stock (8,595 underlying) - 8,334
Stock Option (Right to Buy)
Exercise: $13.87Exp: 2023-12-12→ Common Stock (8,334 underlying) - 7,153
Stock Option (Right to Buy)
Exercise: $20.83Exp: 2026-05-01→ Common Stock (7,153 underlying)
Footnotes (9)
- [F1]On March 1, 2022, Ms. Wallar was granted 11,677 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
- [F2]This balance includes 104 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares wereacquired in transactions exempt from Section 16b-3.
- [F3]On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
- [F4]On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
- [F5]On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F6]On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F7]On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F8]On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F9]On March 1, 2022, Ms. Wallar was granted 28,506 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001869819
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:56 PM ET
- Size
- 19.2 KB